BackNeuroSense Therapeutics Overview

NeuroSense Therapeutics Common Stock

Latest common stock for NRSN: $0.

Get informed when a big investor buys or sells

+ Follow
Common Stock
$0.00

Peer trimmed avg / median

Loading

NeuroSense Therapeutics Common Stock History

Loading

NeuroSense Therapeutics vs. peers: Common Stock Comparison

Loading

NeuroSense Therapeutics Common Stock Growth (YoY per quarter)

Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.

Loading

NeuroSense Therapeutics (NRSN) FAQ

NeuroSense Therapeutics (NRSN) currently reports a common stock of $0 as of December 2025. In the prior-year period, the figure was $0. Use the charts on this page to explore NeuroSense Therapeutics's common stock history and peer comparisons.

NeuroSense Therapeutics's common stock changed from $0 to $0 (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

NeuroSense Therapeutics reported $0 in common stock as of December 2025. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current common stock of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for NeuroSense Therapeutics, and consider following NRSN for alerts when major investors trade the stock.